Bell Bank Has $456,000 Stock Position in Danaher Co. (NYSE:DHR)

Bell Bank lessened its position in Danaher Co. (NYSE:DHR - Free Report) by 56.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,226 shares of the conglomerate's stock after selling 2,913 shares during the period. Bell Bank's holdings in Danaher were worth $456,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in DHR. Kentucky Retirement Systems Insurance Trust Fund boosted its holdings in shares of Danaher by 11.6% in the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after acquiring an additional 2,202 shares in the last quarter. FAS Wealth Partners Inc. boosted its stake in Danaher by 20.6% in the fourth quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock worth $2,203,000 after purchasing an additional 1,639 shares in the last quarter. ICICI Prudential Asset Management Co Ltd bought a new stake in shares of Danaher during the fourth quarter worth $4,591,000. Charles Schwab Investment Management Inc. increased its stake in shares of Danaher by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate's stock valued at $933,524,000 after buying an additional 135,047 shares in the last quarter. Finally, CIBC Asset Management Inc lifted its position in Danaher by 24.4% during the 4th quarter. CIBC Asset Management Inc now owns 254,327 shares of the conglomerate's stock worth $58,308,000 after buying an additional 49,964 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DHR. Citigroup restated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Bank of America dropped their price objective on shares of Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. UBS Group decreased their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Stifel Nicolaus upgraded Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a research report on Friday, March 14th. Finally, Argus decreased their price target on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $248.17.

Danaher Stock Performance

Shares of DHR stock traded down $5.30 during midday trading on Tuesday, hitting $195.81. 2,968,631 shares of the company were exchanged, compared to its average volume of 3,487,351. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The firm has a market capitalization of $140.13 billion, a P/E ratio of 37.08, a PEG ratio of 2.66 and a beta of 0.77. The firm's 50 day moving average price is $193.35 and its two-hundred day moving average price is $210.53. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, equities research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio is 24.85%.

Insider Buying and Selling at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the sale, the chairman now directly owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.